Aldawaa 9M 2022 net profit up 27% to SAR 215.9 mln; Q3 at SAR 48.15 mln

Aldawaa 9M 2022 net profit up 27% to SAR 215.9 mln; Q3 at SAR 48.15 mln

02/11/2022 Argaam Exclusive

View other reports

Aldawaa Medical Services Co. reported a net profit after Zakat and tax of SAR 215.9 million for the first nine months of 2022, an increase of 27%, compared to SAR 170.07 million in the year-earlier period.   

  



Financials (M)

Item 9m 2021 9m 2022 Change‬
Revenues 3,736.04 3,913.94 4.8 %
Gross Income 1,361.32 1,485.91 9.2 %
Operating Income 192.07 243.95 27.0 %
Net Income 170.07 215.94 27.0 %
Average Shares 85.00 85.00 -
EPS (Riyals) 2.00 2.54 27.0 %

The company cited a 4.8% year-on-year (YoY) increase in revenue, and stronger gross and operating profits, in addition to improved sales.  



Current Quarter Comparison (M)

Compared With The
Item Q3 2021 Q3 2022 Change‬
Revenues 1,259.56 1,308.93 3.9 %
Gross Income 451.39 484.94 7.4 %
Operating Income 50.81 82.69 62.7 %
Net Income 38.29 48.15 25.7 %
Average Shares 85.00 85.00 -
EPS (Riyals) 0.45 0.57 25.7 %

Q3 2022 net profit after Zakat and tax increased 26% YoY to SAR 48.2 million, from SAR 38.29 million in a prior-year period, on a 4% YoY rise in revenue, 37% YoY higher gross profit, a 6.3% YoY growth in operating profit and stronger sales. 

 

On a sequential basis, net profit dropped 40.3% from SAR 80.67 million. 

 

Total shareholders’ equity, excluding minority rights, reached SAR 1.025 billion as of Sept. 30, 2022, compared to SAR 1.059 billion in prior-year period.  



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2013 - - - - - -
Q2 2013 - - - - - -
Q3 2013 - - - - - -
Q4 2013 - - - - - -
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 1,176.38 - 446.33 - 91.48 -
Q2 2020 1,303.84 - 530.76 - 131.66 -
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 1,209.72 2.8 % 451.96 1.3 % 74.35 (18.7 %)
Q2 2021 1,266.77 (2.8 %) 457.98 (13.7 %) 66.91 (49.2 %)
Q3 2021 1,259.56 - 451.39 - 50.81 -
Q4 2021 1,298.34 - 533.08 - 75.82 -
Q1 2022 1,294.82 7.0 % 494.18 9.3 % 70.71 (4.9 %)
Q2 2022 1,310.19 3.4 % 506.79 10.7 % 90.55 35.3 %
Q3 2022 1,308.93 3.9 % 484.94 7.4 % 82.69 62.7 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
Q1 2013 - - - - - -
Q2 2013 - - - - - -
Q3 2013 - - - - - -
Q4 2013 - - - - - -
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 23.11 - 0.29 (52.93) 76.04 0.95
Q2 2020 55.35 - 0.69 (61.91) 117.26 1.47
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 78.84 241.2 % 0.99 21.49 57.35 0.72
Q2 2021 52.94 (4.4 %) 0.62 5.84 47.10 0.55
Q3 2021 38.29 - 0.45 9.85 28.44 0.33
Q4 2021 69.08 - 0.81 26.24 42.84 0.50
Q1 2022 87.11 10.5 % 1.02 38.14 48.97 0.58
Q2 2022 80.67 52.4 % 0.95 14.47 66.21 0.78
Q3 2022 48.15 25.7 % 0.57 (1.08) 49.24 0.58

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 37.63 % 11.95 % 3.49 %
Q1 2022 37.83 % 12.05 % 3.27 %
Q2 2022 38.46 % 12.59 % 3.61 %
Q3 2022 38.74 % 13.20 % 3.98 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2013 - - - -
Q2 2013 - - - -
Q3 2013 - - - -
Q4 2013 - - - -
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 79.85 - - -
Q2 2020 79.85 - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 79.85 - - 14.62
Q2 2021 85.00 - - 14.74
Q3 2021 85.00 - - 12.46
Q4 2021 85.00 2.81 2.07 11.64
Q1 2022 85.00 2.91 1.97 12.61
Q2 2022 85.00 3.24 2.19 12.78
Q3 2022 85.00 3.35 2.44 12.07

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 25.59 37.84 5.91
Q2 2022 20.70 30.54 5.24
Q3 2022 23.77 32.69 6.61

Business Segments (Million)

Compared With The
Period Retail Sales Wholesale
Q1 2021 1,169.76 39.96
Q2 2021 1,234.85 31.92
Q3 2021 1,224.38 35.18
Q4 2021 1,257.00 41.34
Q1 2022 1,260.57 34.25
Q2 2022 1,268.35 41.84
Q3 2022 1,261.85 47.08

Current
Market Cap (M Riyal) 6,808.50
Enterprise Value (EV) (M) 7,366.97
Shares Outstanding ((M)) 85.00
EPS ( Riyal) (TTM) 4.22
Book Value (BV) ( Riyal) 16.65
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 18.98
P/E (TTM) 18.98
Price/book 4.81
Return on Average Assets (%) (TTM) 7.5
Return on Average Equity (%) (TTM) 27.4

Share Price

Aldawaa Medical Services Co. (ALDAWAA)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.